Cecile Geuijen, PhD

Vice President, Oncology - Cell Biology at Merus, The Netherlands

Speaker

Cecile Geuijen joined Merus in 2009 and holds a Ph.D. in Biology from the University of Utrecht. Before joining Merus she worked on the identification of new therapeutic targets in oncology at Crucell and evaluated new therapeutic targets in oncology at Genmab. She is responsible for the functional screenings of large Biclonics® antibody panels at Merus. She serves as project leader of several (pre) clinical bispecific candidate combinations including the pre-clinical work of MCLA-128 and MCLA-145 with a focus on mechanism of action studies.